226 related articles for article (PubMed ID: 197414)
41. Desensitization of prostaglandin-activated platelet adenylate cyclase.
Cooper B; Schafer AI; Puchalsky D; Handin RI
Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
[TBL] [Abstract][Full Text] [Related]
42. SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
Seiler S; Brassard CL; Federici ME
Prostaglandins; 1990 Aug; 40(2):119-30. PubMed ID: 2171039
[TBL] [Abstract][Full Text] [Related]
43. Proteolysis of the platelet surface: dissociation of shape change from aggregation.
Kornecki E; Ehrlich YH; Hardwick DH; Lenox RH
Am J Physiol; 1986 Apr; 250(4 Pt 2):H550-7. PubMed ID: 3008579
[TBL] [Abstract][Full Text] [Related]
44. Effect of lithium on prostaglandin F1-stimulated adenylate cyclase activity of human platelets.
Wang YC; Pandey GN; Mendels J; Frazer A
Biochem Pharmacol; 1974 Feb; 23(4):845-55. PubMed ID: 4363215
[No Abstract] [Full Text] [Related]
45. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
46. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
Willis AL; Comai K; Kuhn DC; Paulsrud J
Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
[No Abstract] [Full Text] [Related]
47. Lag-phase of arachidonic acid-induced secretion in responders and non-responders to the thromboxane-synthetase inhibitors: involvement of cyclic-AMP.
Lecompte T; Joussemet M; Hainaut J
Thromb Res; 1984 Jul; 35(1):91-7. PubMed ID: 6089368
[No Abstract] [Full Text] [Related]
48. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
49. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
Rao AK; Willis J; Kowalska MA; Wachtfogel YT; Colman RW
Blood; 1988 Feb; 71(2):494-501. PubMed ID: 2827817
[TBL] [Abstract][Full Text] [Related]
50. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
[No Abstract] [Full Text] [Related]
51. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
52. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
Jaschonek K; Faul C; Daiss W; Weisenberger H
Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
[TBL] [Abstract][Full Text] [Related]
53. Platelet adenylate cyclase responses in depression: implications for a receptor defect.
Wang YC; Pandey GN; Mendels J; Frazer A
Psychopharmacologia; 1974 May; 36(4):291-300. PubMed ID: 4367922
[No Abstract] [Full Text] [Related]
54. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
MacIntyre DE; Salzman EW; Gordon JL
Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
[TBL] [Abstract][Full Text] [Related]
55. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
Reches A; Eldor A; Salomon Y
Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
[No Abstract] [Full Text] [Related]
56. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
57. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
Kahn NN; Sinha AK
Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
[TBL] [Abstract][Full Text] [Related]
59. Effect of chilling on platelet cyclic adenosine 3:5-monophosphate and adenylate cyclase activity.
Zappia GC; Steiner M; Ando Y; Baldini M
Transfusion; 1976; 16(2):122-9. PubMed ID: 176753
[TBL] [Abstract][Full Text] [Related]
60. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
